pyrroles has been researched along with Dermatoses in 25 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (12.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (20.00) | 29.6817 |
| 2010's | 16 (64.00) | 24.3611 |
| 2020's | 1 (4.00) | 2.80 |
| Authors | Studies |
|---|---|
| Deguchi, N; Kawamura, T; Mitsui, H; Muto, Y; Ogawa, Y; Shimada, S | 1 |
| Ezzedine, K | 1 |
| Damsky, W; Emeagwali, N; Galan, A; King, B; Thakral, D | 1 |
| Aguilar-Luque, M; Gay-Mimbrera, J; Gómez-Arias, PJ; Gómez-García, F; Hernandez, J; Isla-Tejera, B; Montilla, AM; Ruano, J; Velez García-Nieto, A; Viguera-Guerra, I | 1 |
| Fraser, K | 1 |
| Gupta, S; Gupta, V; Rao, A | 1 |
| Chia, WT; Chiang, WL; Hsiao, HC; Lin, TT; Liu, HY; Sung, HW; Sureshbabu, R; Yang, CM | 1 |
| Choi, J; King, B; Lee, AI | 1 |
| Ahmad Nasrollahi, S; Firooz, A; Hashemi, A; Nassiri Kashani, M; Samadi, A | 1 |
| Ceovic, R; Gulin, SJ; Kostovic, K; Mokos, ZB | 1 |
| Damsky, W; King, BA | 1 |
| Barnes, K; Cavalcanti, JVJ; Dange, RB; Hasbach, A; Patterson, J; Saavedra, PV | 1 |
| Ramot, Y; Shreberk-Hassidim, R; Zlotogorski, A | 1 |
| Chang, SE; Choi, JH; Kang, YK; Koh, JK; Lee, JL; Lee, MW; Lee, WJ; Moon, KC | 1 |
| Grünwald, V; Kalanovic, D; Merseburger, AS | 1 |
| Cortesi, E; Iacovelli, R; Mancini, ML; Palazzo, A; Risi, E | 1 |
| Barbault-Foucher, S; Le Beller, C; Martin, C; Mateus, C; Rieutord, A; Vignand-Courtin, C | 1 |
| Chou, CY; Lin, YH; Lin, YT; Tsai, HH; Wang, KH | 1 |
| Brown, BE; Choi, EH; Crumrine, D; Demerjian, M; Elias, PM; Feingold, KR; Mauro, T | 1 |
| Cho, CY; Gray, NS; Hong, J; Lee, J; Min, KH; Peters, EC; Schultz, PG; Walker, JR | 1 |
| Robert, C | 1 |
| Burgin, S; Heidary, N; Naik, H | 1 |
| Scarzella, M | 1 |
| Eyre, P; Lewis, AJ; Wells, PW | 1 |
| Goldberg, A | 1 |
9 review(s) available for pyrroles and Dermatoses
| Article | Year |
|---|---|
[What's new in dermatological therapy?]
Topics: Adalimumab; Anti-Bacterial Agents; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Dermatologic Agents; Dermatology; Erlotinib Hydrochloride; Herpes Zoster Vaccine; Humans; Interleukin 1 Receptor Antagonist Protein; Isotretinoin; Piperidines; Protein Kinase Inhibitors; Pyrimidines; Pyrroles; Skin Diseases; Trimethoprim, Sulfamethoxazole Drug Combination | 2016 |
Drugs targeting the JAK/STAT pathway for the treatment of immune-mediated inflammatory skin diseases: protocol for a scoping review.
Topics: Humans; Janus Kinase Inhibitors; Janus Kinases; Nitriles; Piperidines; Pyrazoles; Pyrimidines; Pyrroles; Skin Diseases; STAT Transcription Factors | 2019 |
Janus kinase (JAK) inhibitors for the treatment of skin and hair disorders: a review of literature.
Topics: Alopecia Areata; Azetidines; Dermatitis, Atopic; Humans; Janus Kinase Inhibitors; Janus Kinases; Nitriles; Piperidines; Psoriasis; Purines; Pyrazoles; Pyrimidines; Pyrroles; Skin Diseases; Sulfonamides; Vitiligo | 2017 |
Tofacitinib, an Oral Janus Kinase Inhibitor: Perspectives in Dermatology.
Topics: Administration, Oral; Alopecia Areata; Dermatitis, Atopic; Humans; Janus Kinases; Piperidines; Protein Kinase Inhibitors; Psoriasis; Pyrimidines; Pyrroles; Signal Transduction; Skin Diseases; Vitiligo | 2017 |
JAK inhibitors in dermatology: The promise of a new drug class.
Topics: Alopecia Areata; Anti-Inflammatory Agents; Azetidines; Clinical Trials as Topic; Dermatitis, Atopic; Dermatologic Agents; Humans; Janus Kinases; Molecular Targeted Therapy; Nitriles; Piperidines; Protein Kinase Inhibitors; Psoriasis; Purines; Pyrazoles; Pyrimidines; Pyrroles; Signal Transduction; Skin Diseases; Sulfonamides; Vitiligo | 2017 |
Janus kinase inhibitors in dermatology: A systematic review.
Topics: Alopecia Areata; Anti-Inflammatory Agents; Antineoplastic Agents; Azetidines; Dermatologic Agents; Drug Eruptions; Humans; Janus Kinases; Molecular Targeted Therapy; Nitriles; Piperidines; Protein Kinase Inhibitors; Psoriasis; Purines; Pyrazoles; Pyrimidines; Pyrroles; Randomized Controlled Trials as Topic; Signal Transduction; Skin Diseases; Sulfonamides | 2017 |
Management of sunitinib-related adverse events: an evidence- and expert-based consensus approach.
Topics: Carcinoma, Renal Cell; Consensus; Diarrhea; Dose-Response Relationship, Drug; Drug Administration Schedule; Early Detection of Cancer; Evidence-Based Medicine; Fatigue; Female; Follow-Up Studies; Humans; Hypertension; Indoles; Kidney Neoplasms; Male; Mouth Diseases; Practice Guidelines as Topic; Protein Kinase Inhibitors; Pyrroles; Risk Assessment; Skin Diseases; Sunitinib; Treatment Outcome | 2010 |
[Cutaneous side effects of antiangiogenic agents].
Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Benzenesulfonates; Bevacizumab; Drug Eruptions; Humans; Indoles; Niacinamide; Phenylurea Compounds; Pigmentation Disorders; Pyridines; Pyrroles; Skin Diseases; Sorafenib; Sunitinib | 2007 |
Chemotherapeutic agents and the skin: An update.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antimetabolites; Antineoplastic Agents; Benzamides; Benzenesulfonates; Cetuximab; Drug Eruptions; Drug-Related Side Effects and Adverse Reactions; ErbB Receptors; Erlotinib Hydrochloride; Fusion Proteins, bcr-abl; Gefitinib; Hair Diseases; Humans; Imatinib Mesylate; Indoles; Mucous Membrane; Nail Diseases; Niacinamide; Phenylurea Compounds; Piperazines; Platinum Compounds; Proteasome Inhibitors; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Pyridines; Pyrimidines; Pyrroles; Quinazolines; Signal Transduction; Skin; Skin Diseases; Sorafenib; Sunitinib; Taxoids | 2008 |
16 other study(ies) available for pyrroles and Dermatoses
| Article | Year |
|---|---|
Case of cutaneous sarcoidosis treated with delgocitinib 0.5% ointment.
Topics: Emollients; Humans; Ointments; Pyrroles; Sarcoidosis; Skin Diseases | 2021 |
Tofacitinib Treatment and Molecular Analysis of Cutaneous Sarcoidosis.
Topics: Female; Humans; Immunohistochemistry; Janus Kinases; Middle Aged; Piperidines; Protein Kinase Inhibitors; Pyrimidines; Pyrroles; Remission Induction; Sarcoidosis; Sarcoidosis, Pulmonary; Sequence Analysis, RNA; Signal Transduction; Skin; Skin Diseases; STAT Transcription Factors | 2018 |
72nd annual meeting of the American Academy of Dermatology.
Topics: Antifungal Agents; Attention Deficit Disorder with Hyperactivity; Boron Compounds; Botulinum Toxins, Type A; Bridged Bicyclo Compounds, Heterocyclic; Brimonidine Tartrate; Depression; Dermatitis, Atopic; Food Hypersensitivity; Humans; Immunologic Factors; Ivermectin; Phosphodiesterase Inhibitors; Phototherapy; Piperidines; Protein Kinase Inhibitors; Pyrimidines; Pyrroles; Quinoxalines; Skin Diseases; Societies, Medical; Thalidomide; Triazoles; United States | 2014 |
Scrotal cutaneous toxicity: an uncommon but important side-effect of sunitinib.
Topics: Antineoplastic Agents; Humans; Indoles; Kidney Neoplasms; Male; Middle Aged; Pyrroles; Scrotum; Skin Diseases; Sunitinib | 2016 |
A rapid drug release system with a NIR light-activated molecular switch for dual-modality photothermal/antibiotic treatments of subcutaneous abscesses.
Topics: Abscess; Animals; Anti-Bacterial Agents; Drug Delivery Systems; Hot Temperature; Infrared Rays; Injections, Subcutaneous; Lactic Acid; Methicillin-Resistant Staphylococcus aureus; Mice; Mice, Inbred BALB C; Microspheres; Nanoparticles; Photochemistry; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Pyrroles; Skin Diseases; Tissue Distribution; Vancomycin; Wound Healing | 2015 |
Treatment of Hypereosinophilic Syndrome with Cutaneous Involvement with the JAK Inhibitors Tofacitinib and Ruxolitinib.
Topics: Adult; Aged; Female; Humans; Hypereosinophilic Syndrome; Janus Kinase Inhibitors; Male; Middle Aged; Nitriles; Piperidines; Pyrazoles; Pyrimidines; Pyrroles; Skin Diseases | 2017 |
Skin depigmentation associated with toceranib phosphate in a dog.
Topics: Animals; Antineoplastic Agents; Dog Diseases; Dogs; Indoles; Male; Mastocytosis; Pyrroles; Skin; Skin Diseases; Skin Pigmentation | 2017 |
Cutaneous adverse effects in patients treated with the multitargeted kinase inhibitors sorafenib and sunitinib.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Alopecia; Antineoplastic Agents; Benzenesulfonates; Carcinoma, Hepatocellular; Carcinoma, Renal Cell; Drug Eruptions; Female; Foot Dermatoses; Gastrointestinal Stromal Tumors; Hand Dermatoses; Humans; Indoles; Kidney Neoplasms; Male; Middle Aged; Niacinamide; Phenylurea Compounds; Protein Kinase Inhibitors; Pyridines; Pyrroles; Retrospective Studies; Skin Diseases; Sorafenib; Stomatitis; Sunitinib; Young Adult | 2009 |
Genital and inguinal cutaneous toxicity in male and female patients treated with sunitinib.
Topics: Aged; Antineoplastic Agents; Carcinoma, Renal Cell; Female; Genital Diseases, Male; Humans; Indoles; Kidney Neoplasms; Male; Pyrroles; Scrotum; Skin Diseases; Sunitinib; Vulvar Diseases | 2012 |
Cutaneous side effects associated with sunitinib: an analysis of 8 cases.
Topics: Adult; Antineoplastic Agents; Female; France; Humans; Indoles; Male; Middle Aged; Prognosis; Protein Kinase Inhibitors; Pyrroles; Retrospective Studies; Risk Assessment; Risk Factors; Skin; Skin Diseases; Sunitinib | 2012 |
Sunitinib-induced scrotal cutaneous side-effect.
Topics: Aged; Antineoplastic Agents; Humans; Indoles; Male; Pyrroles; Scrotum; Skin Diseases; Sunitinib | 2013 |
Glucocorticoid blockade reverses psychological stress-induced abnormalities in epidermal structure and function.
Topics: Animals; Dose-Response Relationship, Drug; Epidermis; Female; Glucocorticoids; Mice; Mice, Hairless; Mifepristone; Pyrimidines; Pyrroles; Skin Diseases; Stress, Psychological | 2006 |
Identification and characterization of small-molecule inducers of epidermal keratinocyte differentiation.
Topics: Cell Differentiation; Cell Division; Epidermal Cells; Epidermis; Humans; Keratinocytes; Pyrimidines; Pyrroles; Skin Diseases; Stem Cells | 2007 |
[Distamycin A in the treatment of cutaneous localizations of herpes virus and of complications of jennerian vaccination].
Topics: Chickenpox; Child; Child, Preschool; Female; Herpesviridae Infections; Humans; Infant; Infant, Newborn; Male; Pyrroles; Skin Diseases; Smallpox; Stomatitis; Vaccination | 1970 |
Cutaneous reaction to prostaglandins E 1 ,E 2 and F 2 in the bovine.
Topics: Animals; Bradykinin; Capillary Permeability; Cattle; Histamine; Histamine Antagonists; Histamine H1 Antagonists; Inflammation; Injections, Intradermal; Mast Cells; p-Methoxy-N-methylphenethylamine; Prostaglandins; Pyrroles; Skin; Skin Diseases | 1972 |
Diagnosis and treatment of the porphyrias.
Topics: Acute Disease; Amino Acids; Erythropoiesis; Feces; Female; Humans; Levulinic Acids; Liver Diseases; Male; Photosensitivity Disorders; Porphyrias; Porphyrins; Pyrroles; Skin Diseases; Skin Manifestations | 1968 |